Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years

BACKGROUND: Chronic obstructive pulmonary disease is a major inflammatory disease of the airways and an enormous therapeutic challenge. Within the spectrum of chronic obstructive pulmonary disease, pulmonary emphysema is characterized by the destruction of the alveolar walls with an increase in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Stessuk, Talita, Ruiz, Milton Artur, Greco, Oswaldo Tadeu, Bilaqui, Aldemir, Ribeiro-Paes, Maria José de Oliveira, Ribeiro-Paes, João Tadeu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Hematologia e Hemoterapia 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832317/
https://www.ncbi.nlm.nih.gov/pubmed/24255620
http://dx.doi.org/10.5581/1516-8484.20130113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832317/
https://www.ncbi.nlm.nih.gov/pubmed/24255620
http://dx.doi.org/10.5581/1516-8484.20130113

Ejemplares similares